Year-end report 2009: Six newly started clinics during the year

Year-end report 2009: Six newly started clinics during the year

Fourth quarter 2009
• Revenues increased by 13 percent to SEK 151.2 million (133.7)
• The result before tax amounted to SEK -5.9 million (-18.2)
• The result per share amounted to SEK -0.19 (-0.24)
• The operating result amounted to SEK -2.9 million (-17.7)
• Organic growth of 13 percent

Whole year 2009
• Revenues increased by 26 percent to SEK 503.3 million (400.4)
• The result before tax amounted to SEK -11.2 million (-37.5)
• The result per share amounted to SEK -0.45 (-0.71)
• The operating result amounted to SEK -7.2 million (-32.5)
• Continuing good organic growth of 21 percent

Comments from Per Båtelson, CEO:
2009 was an eventful year, with a mixture of successes and breakthroughs, but
also with some challenges which required that measures be taken during the
autumn. Our mature clinics continued to develop well during the year, as did
most of our newly started clinics. 2009 was therefore the first time that we
achieved a positive whole-year result before close-down costs in England,
despite increasing development and start-up costs for the Group as a whole.

Market conditions in Sweden were affected positively by the greater political
will to meet the health care guarantee for an increasing number of patients with
the aid of private providers of hospital care, and by the increasing number of
patients with private health insurance. The greatest challenge during the autumn
was the restructuring of our operations in England. Given the prevailing market
conditions, we consider that we can use our resources better in other markets.
We closed our dental clinic in Leeds and concentrated our efforts within the
obesity area on only treating publicly funded patients.

The successes during the year include:
• The contract giving us responsibility for the treatment of diabetes patients
in Ajman, United Arab Emirates. The hospital is in the process of being started
up and will be operational from April 2010.  A clinic for supplementary obesity
surgery will also be opened under the Global Health Partner's management and we
will be precursors in being able to offer surgery as a new way of treating
diabetes.
• The start of our first Arrhythmia clinic at Södersjukhuset hospital in
Stockholm. The business has treated more than 150 patients with severe heartbeat
problems since it was started in May 2009, with very good treatment results.
• The good development of volume and financial results, especially in our
Swedish orthopaedic clinics.
• Not withstanding the increased business development to expand the group as
well as the work to document and develop quality and efficiency, the
consolidation of our central resources has resulted in reduced central costs.

During the fourth quarter we started a business for obesity surgery in Prague.
Our own, completely new clinic will be ready for occupancy during April 2010,
and it will also be ready to expand in other Service Line areas. We also started
obesity surgery in Helsinki during November 2009. 

The closure of the dental clinic in Leeds, the restructuring of the obesity
surgery investment and the reduction of the central resources in England will
have a positive effect on financial results as well as the group's risk profile
for 2010 compared with 2009. Together with the consolidation of central
resources in the Parent Company and continuing good development for our
established clinics, this makes us confident that we are well-positioned for
2010. 

26 February 2010
Gothenburg

The Board

Queries should be addressed to:
Per Båtelson, CEO, +46-705 95 57 00
Anna Ahlberg, IR, +46-708 55 38 35


Global Health Partner operates specialist clinics that focus on selected
treatment areas (Spine, Dental, Bariatrics and Orthopaedics) using a business
model unique in the Swedish healthcare sector in which leading physicians become
partners and shareholders. Operating clinics with a high patient volume in a
particular treatment area leads to a higher level of efficiency and quality.
This concept of “Quality through Specialisation” is the foundation for the
clinics and Global Health Partner's operations. Global Health Partner's shares
are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation
“GHP.”

Global Health Partner AB (publ) | www.globalhealthpartner.com
Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden
Tel +46 (0)31-712 53 00 | Fax +46 (0)31-313 13 21

Global Health Partner AB is required to publish the information herein under the
Swedish Securities Market Act. This information was submitted for disclosure on
26 February 2010 at 8.00 a.m. CET.

This is a translation of the Swedish version of the Year-end report. When in
doubt, the Swedish wording prevails.